← Insider buys
BMRN

BioMarin Pharmaceutical Inc. · Healthcare

CEO Jean Jacques Bienaime sold $328K of BioMarin Pharmaceutical Inc.

Sold$327,888
$81.97Price
4,000Shares
−1%Stake

What BMRN did after the filing

Prices for BMRN after this filing aren't in yet.

Traded Thu, May 9. Filed Mon, May 13, 7:08 PM ET, after the close. Not investment advice.